Boothbay Fund Management, LLC Dbv Technologies S.A. Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.71 - $5.92 $59,440 - $74,710	-12,620 Reduced 27.75%	32,861 $161,000
Q1 2021 May 17, 2021	SELL	$2.75 - $6.57 $13,796 - $32,961	-5,017 Reduced 9.94%	45,481 $242,000
Q4 2020 Feb 12, 2021	BUY	$1.38 - $3.01 $29,531 - $64,413	21,400 Added 73.54%	50,498 $132,000
Q2 2020 Aug 14, 2020	BUY	$3.74 - $6.28 $108,826 - $182,735	29,098 New	29,098 $128,000
Q1 2020 May 15, 2020	SELL	$2.33 - $12.98 $48,133 - $268,140	-20,658 Closed	0 $0

Q4 2019 Feb 14, 2020	BUY	$6.75 - $11.15 $139,441 - $230,336	20,658 New	20,658 $221,000

37.7M

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $175M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.